ZALEPLON Detail
ZALEPLON
NDA 077238
ZALEPLON
GENPHARM
July 25, 2006
| Active Ingredients | Strenght | Dosage Form | Marketing Status | TE Code |
|---|---|---|---|---|
| ZALEPLON | 5MG | CAPSULE; ORAL | Tentative approval | none |
Zaleplon (marketed as Sonata) Information
Sonata is used to treat short-term difficulty in falling asleep. Sonata has been shown to decrease the time to sleep onset for up to 30 days in clinical studies. Sonata has not been shown to increase your total sleep time or decrease the number of times you wake up after falling asleep.
- FDA News: FDA Requests Label Change for All Sleep Disorder Drug Products
- Patient Information Sheet
